Ethics and Compliance
At Exelixis, we strive for the highest standards of business conduct and ethics. Our Code of Conduct and Ethics reflects the business practices and principles of behavior that support this commitment. We are dedicated to creating a culture that encourages responsible corporate action at every level in our organization. It is expected that all of Exelixis’ officers, employees, directors, agents and contractors will maintain the standards established in our Code of Conduct and Ethics, and adhere to the policies created in support of the code.
In addition, we are committed to sustaining an effective Healthcare Compliance Program in accordance with applicable laws and guidelines established by the federal and/or state government. We achieve this through programs and company policies, as well as training designed to prevent, detect, and correct any potential violations.
California Compliance Declaration
Exelixis, Inc. is committed to establishing and maintaining a comprehensive and effective compliance program in accordance with California SB 1765 (California Business & Professions Code 119400, 119402), and the Office of Inspector General, U.S. Department of Health and Human Services, “Compliance Program Guidance for Pharmaceutical Manufacturers” (OIG Guidance).
Our Compliance Program reflects our unwavering commitment to the highest standards of corporate conduct and integrity.
Click here to view our Comprehensive Compliance Program.
Vermont Pharmaceutical Marketer Price Disclosure
Vermont law 18 V.S.A. § 4633 requires pharmaceutical marketers to disclose to Vermont doctors and other prescribers the prices of the drugs they market as well as the prices of other drugs in the same therapeutic class.
This page allows those doctors and other prescribers’ access to this information for applicable products that are manufactured and marketed by Exelixis.
Please choose either “Long form” or “Short form” below.